Nabi Biopharmaceuticals to Present At Noble Financial's Fifth Annual Equity Conference

Tuesday, June 02, 2009 10:41 AM

ROCKVILLE, Md., June 2, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that Dr. Raafat Fahim, President and Chief Executive Officer, will present at Noble Financial Capital Markets Fifth Annual Equity Conference held June 8-9, 2009 at the Hard Rock Hotel & Casino in Hollywood, Florida. Dr. Fahim's presentation is scheduled for June 8, 2009 at 4:50 p.m., EDT.

You can access the webcast of this presentation on the company's "Events and Webcasts" page at www.nabi.com or at

http://hosted.mediasite.com/mediasite/Viewer/?peid=52189e50b5e54a7da0194725fb4de62e

About Nabi Biopharmaceuticals

Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop products that target serious medical conditions in the areas of nicotine addiction and gram-positive bacterial infections. Nabi Biopharmaceuticals is currently developing NicVAX(r) (Nicotine Conjugate Vaccine), an innovative and proprietary investigational vaccine for treatment of nicotine addiction and prevention of smoking relapse, and PentaStaph(tm) (Pentavalent S. aureus Vaccine), a vaccine designed to protect against the most dangerous and prevalent strains of S. aureus bacterial infections. The company is headquartered in Rockville, Maryland. For additional information about Nabi Biopharmaceuticals, please visit our Web site:http://www.nabi.com.

CONTACT:  Nabi Biopharmaceuticals
          Investor Relations
          301-770-3099
          www.nabi.com

(Source: PrimeZone )

Related Stories